2016
$85M
from 14 investors over 14 rounds
Silverback Therapeutics raised $85M on September 23, 2020
Investors: Nextech Invest, RA Capital Management, L.P., OrbiMed Advisors, Frazier Healthcare Partners and Pontifax Venture Capital
Silverback Therapeutics raised $79M on March 11, 2020
Investors: Nextech Invest, NS Investment, Hunt Investment Co, OrbiMed Advisors, Pontifax Venture Capital and Bristol-Myers Squibb, UK
Silverback Therapeutics raised $10M on October 1, 2019
Investors: OrbiMed Advisors
Silverback Therapeutics raised $38M on September 19, 2018
Investors: OrbiMed Advisors and Celgene